Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) Cash from Investing Activities (2017 - 2021)

Historic Cash from Investing Activities for Cogent Biosciences (COGT) over the last 4 years, with Q4 2021 value amounting to -$433000.0.

  • Cogent Biosciences' Cash from Investing Activities changed N/A to -$433000.0 in Q4 2021 from the same period last year, while for Dec 2021 it was -$1.6 million, marking a year-over-year decrease of 11960.04%. This contributed to the annual value of $38.3 million for FY2024, which is 13912.74% up from last year.
  • As of Q4 2021, Cogent Biosciences' Cash from Investing Activities stood at -$433000.0.
  • Cogent Biosciences' 5-year Cash from Investing Activities high stood at $15.0 million for Q4 2018, and its period low was -$41.4 million during Q2 2018.
  • Its 4-year average for Cash from Investing Activities is $1.8 million, with a median of $4.3 million in 2017.
  • Examining YoY changes over the last 5 years, Cogent Biosciences' Cash from Investing Activities showed a top increase of 82256.1% in 2018 and a maximum decrease of 119357.65% in 2018.
  • Over the past 4 years, Cogent Biosciences' Cash from Investing Activities (Quarter) stood at $4.9 million in 2017, then skyrocketed by 206.12% to $15.0 million in 2018, then crashed by 100.09% to -$13000.0 in 2019, then tumbled by 3230.77% to -$433000.0 in 2021.
  • Its last three reported values are -$433000.0 in Q4 2021, -$1.2 million for Q3 2021, and -$13000.0 during Q4 2019.